Context: Irisin has been proposed to be a myokine mediating the effect of exercise on adipocyte browning. The physiology of irisin in humans is not completely understood.
other tissues such as fat, liver, and pancreas, and act locally on muscle to exert metabolic effects in an autocrine/paracrine/endocrine manner (4) .
Irisin is a recently discovered myokine, produced by proteolytic cleavage of the membrane protein, fibronectin type III domain-containing protein 5 (FNDC5) (5) . Regulated mainly by PPAR␥ coactivator 1 alpha (PGC1␣), irisin is suggested to mediate some of the beneficial effects of exercise by inducing uncoupling protein 1 (UCP1) and subsequently increasing energy expenditure in white adipocytes, a process called adipocyte browning (5) . Brown fat has been shown to exert antiobesity and antidiabetic effects in murine models, and correlate with leanness in humans (6 -8) . Recent studies have suggested that in addition to classic brown adipocytes within brown fat in human adults, inducible brown adipocytes, or beige/brite adipocytes, may also play a role in human metabolism (9, 10) . Thus, irisin has been proposed as an attractive therapeutic tool to treat metabolic disorders.
Following the discovery of irisin (5) , studies have explored the irisin/FNDC5 response to exercise. Studies including ours have shown a significant increase in the circulating irisin after an acute bout of exercise (11) (12) (13) (14) , whereas the effect of exercise training on circulating irisin and muscle FNDC5 expression seems controversial (5, (15) (16) (17) (18) (19) . In general, the response to exercise depends on intrinsic factors, such as intensity, duration, and mode of exercise, and external factors including age, nutritional status, and body composition (3) . Whether the irisin response to exercise differs between old and young subjects, as well as physically active and sedentary subjects remains unknown. In this study, we compared irisin levels at baseline, explored the time-course of circulating irisin in response to exercise, and compared this response according to age and fitness level.
Although muscle is considered the primary organ expressing irisin, the potential existence of a feedback loop and its effects on myocyte metabolism have not been fully investigated in humans. We have previously observed a positive correlation between irisin and follistatin, a myokine that regulates muscle growth, at both mRNA and serum levels (20) , and showed that irisin regulates muscle growth-related genes through ERK pathway (21) . We also reported that intermittent sprinting, which causes a drop in muscle ATP content, evoked a significant rise in serum irisin, whereas repetition of this exercise for eight weeks did not cause any changes in either muscle ATP or serum irisin (11) . Based on these observations, we hypothesized that irisin may be induced during a state of energy need and, in return, exert metabolic effects on muscle. AMPactivated protein kinase (AMPK) is a metabolic sensor and a key enzyme in muscle metabolism. A number of myokines, including interleukin-6 (IL-6), have been reported to regulate muscle metabolism (4) through AMPK. To test this hypothesis, we utilized primary human skeletal muscle cells (HSMCs) and studied whether increased irisin regulates AMPK and, subsequently, whether irisin alters the glucose and lipid metabolism in HSMCs. glycogen phosphorylase; GYS1, glycogen synthase; CPT1b, carnitine palmitoyl transferase 1b 
Materials and Methods

Exercise study 1: Effect of age and fitness level on circulating irisin
Seventy-eight healthy men were recruited and divided into two groups by either age or fitness level as shown in Table 1 . Basal fitness level was determined by maximal oxygen uptake (VO 2 max) and individuals with VO 2 max higher than 35 ml/kg/ min for old participants and 45 ml/kg/min for young participants were considered physically active. The cut-off points used correspond to 70th percentile of the population, and are reasonable for dividing the two groups (22, 23) . All participants were nonsmokers, free of musculoskeletal problems, received no antihypertensive medications, and had no signs of cardiovascular/respiratory complications. They also had normal dietary habits and did not consume aspirin, antioxidant compounds (including vitamins and minerals), certain medications (ie, probucol, nebivolol, and anti-inflammatory agents) and alcoholic beverages, at least two weeks prior to the study.
The exercise protocol consisted of running for 45 minutes on a treadmill at 70%-75% of VO 2 max, then at 90% of VO 2 max until exhaustion. At the end of the test, exercise time to exhaustion was recorded in minutes. This single bout of exercise to exhaustion was confirmed to induce significant oxidative and metabolic challenges (23) . Blood was collected before and immediately after (in 10 -15 minutes) exercise for plasma preparation. (24) . Swimming time for the 2000-m test was 27 minutes 37 seconds Ϯ 22 seconds, corresponding to a swimming velocity of 1.21 Ϯ 0.02 m/s, whereas the average swimming time at each of the six maximal 50-m swimming bouts was 32.23 Ϯ 0.47 seconds, corresponding to a swimming velocity of 1.56 Ϯ 0.02 m/s. The two exercise tests were performed on separate days, spaced one week apart, in a random order. Blood samples were drawn pre-exercise, immediately (in less than 5 minutes), 1 hour, and 24 hrs postexercise for plasma preparation. For determination of blood lactate, capillary blood was taken after warm-up and immediately after CME or 2, 4, 6 and 8 minutes after completion of the ⌯⌱⌱⌭ (the highest value recorded as peak postexercise lactate value).
Exercise study 2: Effect of exercise intensity on circulating irisin
Exercise study 3: Exercise-induced gene expression in humans
Muscle biopsy (50 mg) was performed in vastus lateralis of young, moderately trained, healthy males (age 20.5 Ϯ 1.5 years, BMI 21.9 Ϯ 1.6 kg/m 2 ) before and after 8 weeks of sprint training. The training included a total of four to six 80-m sprint runs per session, three sessions a week (25) . The samples were utilized for gene expression analysis.
In vitro study in HSMCs. Thigh muscle (vastus lateralis) was col-lected from obese but apparently healthy subjects (age 41.0 Ϯ 7.9 years, BMI 43.5 Ϯ 1.7 kg/m 2 ) and cultured as previously described (26) . Briefly, tissue was minced and incubated in 37°C for 1 hour in the dissociation media containing 0.1% BSA, 0.25% trypsin-EDTA, and 0.1% collagenase. Isolated cells were grown in Skeletal Muscle Cell Growth Media (PromoCell, Heidelberg, Germany) and after reaching 70%-80% confluence, growth media was switched to Skeletal Muscle Cell Differentiation Media (PromoCell) for the differentiation of myoblasts into myotubes. The morphology and growth of the isolated myocytes were normal and their characteristics were maintained until passage 7. To examine the effects of irisin treatment on HSMCs, the cells were incubated in serum-deprived medium containing 10 or 50 nM recombinant irisin (Phoenix Pharmaceuticals, Burlingame, CA) and harvested for gene expression analysis. For AMPK inhibition, 10 M Compound C (Millipore, Billerica, MA) was added for 2 hrs before irisin stimulation.
All participants and, for adolescents, their guardians were informed about the details and potential risks of the experimental procedure, after which they provided written consent. The study was approved by the Institutional Review Board at Beth Israel Deaconess Medical Center, Aristotle University of Thessaloniki in accordance with the Declaration of Helsinki. In all studies, samples were stored at -80°C until analysis.
Biochemical measurements. Irisin was measured with enzyme immunoassay (EIA) kits (catalog# EK-067-52, Phoenix Pharmaceuticals). The sensitivity of the assay is 6.6 ng/mL and intraassay CV was 4%-6%. A detailed validation on the kit has been published (11, 27, 28) . Insulin, insulin-like growth factor 1 (IGF1), and IGF binding protein 3 (IGFBP3) were measured with Immulite 1000 automated immunometric assays (Siemens Healthcare Diagnostics, Norwood, MA). Myostatin was measured using EIA kit (ALPCO, Salem, NH). Lactate was measured by lactate dehydrogenase (LDH) enzymatic method (Sigma, St. Louis, MO). Glucose and fatty acid uptake were measured using commercially available kits (Cayman Chemical, Ann Arbor, MI and Molecular Devices, Sunnyvale, CA, respectively). ATP was measured in cell lysates with a bioluminescence kit (Promega, Madison, WI). Glycolysis was assessed by the release of lactate in the media (Cayman Chemical). irisin at the same time point, as appropriate. Comparison of percent change in irisin levels from baseline was performed with general linear model adjusted for covariates. For in vitro data, mean values obtained from multiple experiments were compared by ANOVA with subsequent Fisher's significant difference method. Analyses were performed with the SPSS (Chicago, IL) and P values below 0.05 were considered significant.
Results
Baseline irisin levels are lower in old (vs young) and physically active (vs sedentary) subjects
The characteristics of the subjects are shown in Table 1 . Weight was comparable whereas BMI was marginally but significantly different among groups. As expected, body fat percentage was higher in old (vs young) and sedentary (vs physically active) individuals. Baseline irisin levels were lower in the old compared to the young participants while, in age-matched groups, active individuals had lower circulating irisin in comparison to sedentary subjects. Moreover, baseline irisin levels were negatively associated with VO 2 max levels (rϭ-0.188, P ϭ .019). These differences remained significant after adjustment for BMI, percentage body fat, and age.
Circulating irisin were increased after an acute bout of treadmill exercise until exhaustion in the entire sample (pre: 65.0 Ϯ 2.7 vs post: 72.3 Ϯ 3.3 ng/ml, P ϭ .03). However, there was no significant interaction between time and age (P ϭ .69) or fitness level (P ϭ .41). The increment of the irisin level, assessed by either delta change or percentage change from baseline, showed no differences between groups indicating that, despite different baselines, the irisin response to exercise was similar.
Irisin is increased immediately after exercise and correlates with exercise intensity
To examine the time course of irisin secretion postexercise, we measured plasma irisin in 30 adolescents (15 male and 15 female) for up to 24 hrs after continuous moderate-intensity exercise (CME: 2000-m of continuous freestyle swimming) and high-intensity interval exercise (HIIE: six 50-m maximal freestyle swimming bouts). Postexercise blood lactate levels were 5.8 Ϯ 0.3 for CME and 17.3 Ϯ 0.7 mmol/l for HIIE, distinguishing the two as moderate-and high-intensity exercise, respectively.
Baseline irisin levels were comparable between the two exercise regimens (CME: 91.4 Ϯ 5.0, ⌯⌱⌱⌭: 94.2 Ϯ 8.0 ng/mL, P ϭ .51). Plasma irisin tended to increase but was not significantly altered by CME at any of the time points observed ( Figure 1A) . In contrast, irisin was significantly upregulated by HIIE, increasing by 30% in less than 5 minutes after exercise, remaining high after 1 hour and then returning to baseline. Comparison between genders showed that male and female adolescents had similar baseline irisin (males: 97.4 Ϯ 8.5, females: 90.9 Ϯ 9.0 ng/mL, P ϭ .59), but the increment by HIIE was larger in males (Supplemental Figure S1 ). The change in irisin positively correlated with the change in blood lactate (rϭ 0.39, P ϭ .04). In terms of other myokines, plasma myostatin levels were significantly increased, whereas IGFBP3 levels were decreased 24 hrs postexercise, with no differences between exercise regimens (Supplemental Figure S2 ).
Irisin directly induces glucose and fatty acid uptake in human muscle
The results from exercise studies imply a transient increase in irisin after an acute bout of exercise. The physiological significance of this increase is unknown and is difficult to test in vivo. Therefore, HSMCs were treated with recombinant irisin to directly test whether increased irisin could exerts beneficial effect in muscle. As shown in Figure 1B and 1C, irisin treatment for 1 hour resulted in increased glucose and fatty acid uptake in HSMCs, comparable to insulin-induced response.
Irisin regulates gene expression of metabolic enzymes in human muscle
To see whether irisin regulates the transcription of metabolic genes, we treated HSMCs with irisin (control, 10, and 50 nM) in a time-dependent (2, 6 and 24 hrs) manner. As shown in Figure 2 , 2 hrs of irisin treatment caused only minor changes in metabolic gene expression. However, after 6 hrs of treatment, the expression of genes related to glucose metabolism was modulated, including upregulation of glucose transporter 4 (GLUT4) and hexokinase 2 (HK2), as well as downregulation of pyruvate dehydrogenase kinase 4 (PDK4), phosphoenolpyruvate carboxykinase (PEPCK), and glycogen phosphorylase (PYGM). This was followed by upregulation of glycogen synthase (GYS1) and carnitine palmitoyl transferase 1b (CPT1b) at 24 hrs after treatment, suggesting a novel function of irisin to modulate metabolic gene expression in HSMCs. Gene modulation was followed by enhanced lactate production (Supplemental Figure S3 ).
Irisin induces AMPK phosphorylation in human muscle
To elucidate the mechanism(s) underlying the irisininduced changes in muscle metabolism, we measured intracellular ATP in HSMCs and found a significant decrease following 1 hour irisin treatment ( Figure 3A) . Moreover, this decrease coincided with enhanced phos-phorylation of AMPK ( Figure 3B ), indicating that decrease in ATP may be responsible for triggering AMPK phosphorylation and its downstream effects. To confirm whether AMPK signaling were associated with irisin-induced gene regulation, HSMCs were pretreated with AMPK inhibitor compound C. Indeed, compound C effectively prevented irisininduced AMPK phosphorylation and gene expression ( Figure 3C and 3D).
Muscle FNDC5 expression is induced by exercise and regulates metabolic enzymes in vitro and in vivo
To examine the effect of exercise on muscle FNDC5 expression in vitro, HSKCs were treated with exercise mimetics. Both FNDC5 and PGC1␣ mRNAs were increased by ionomycin (Ca 2ϩ ionophore) and forskolin (activator of adenylate cyclase) treatment ( Figures 4A and 4B ). FNDC5 was also induced by IL-6, implying that IL-6 could lie upstream of FNDC5 regulation ( Figure  4C ). In line with the in vitro results, muscle samples obtained from young, moderately trained, healthy males showed that 8 weeks of sprint training significantly induced FNDC5 and PGC1␣ mRNA level (Figure 4D) , along with increased metabolic gene expression ( Figure 4E ).
Discussion
Irisin has gained attention as 'exercise hormone' on the basis that PGC1␣ overexpression and endurance exercise training induces irisin in mice (5, 29) . However, the physiology of irisin in human remains largely unknown. The present report explored irisin at baseline in subjects with different age and fitness level, in response to different exercise intensities in adolescent males and females, and its effects on muscle metabolism in humans. The main findings are that (i) baseline circulating irisin is lower in old (vs young) and active (vs sedentary) subjects, (ii) circulating irisin levels peak immediately after exercise and the increment of irisin depends on exercise intensity, (iii) exercise induces FNDC5 gene expression in vitro and in vivo, and (iv) increased irisin affects muscle metabolism via AMPK activation.
We have previously observed a negative correlation between age and circulating irisin (11) and confirm here that baseline irisin level is lower in older compared to younger subjects. Muscle being the primary organ of FNDC5 expression, it is possible that lower muscle mass in older subjects have resulted in lower level of irisin. Interestingly, in age-matched groups, irisin levels were lower in active compared to sedentary subjects, which seems paradoxical. We and others have reported that, while acute exercise induces circulating irisin levels, chronic exercise training results in either unchanged or even downregulated basal irisin levels (11, 13) . Higher VO 2 max values in active subjects imply that they have improved cardiovascular fitness and thus would require less feedback from muscle (30, 31) . Indeed, the negative association between VO 2 max and irisin levels makes it plausible that lower irisin in active subjects is a result of an adaptive response to higher muscle capacity. A similar phenomenon has been reported with other cytokines including IL-6 (32). Therefore, not only muscle mass but also capacity may be involved in regulation of basal irisin level. Since muscle mass and capacity has not been measured in the current study, the direct cause-and-effect relationship needs to be further examined.
Despite the apparent differences in baseline irisin levels, the increased irisin in response to treadmill exercise was unrelated to age or fitness level. Rather, comparison between high and moderate intensity swimming revealed that exercise intensity, evidenced by postexercise lactate levels, seems to be closely associated with the irisin response. Similar time response was observed when subjects performed 90 minutes treadmill exercise at 60% of VO 2 max (12) . In this report, irisin was measured before, during (54 minutes), and after (90 minutes) exercise and irisin was significantly increased only at 54 minutes. Therefore, it is possible that irisin bursts out at initial stage of the exercise and declines thereafter, meaning that no change could be observed at the final stage in exercises that last more than 1 hour. It is interesting to note a larger increase in irisin levels in male compared to female adolescents immediately after acute swimming. The larger increment in males might be due to their higher muscle mass, which would have served as a greater source of irisin secretion. Whether there is difference in regulation of irisin secretion between genders needs to be clarified in larger studies.
The transient increase in irisin after an acute bout of exercise is not likely to be effective in browning, which is more of a chronic effect. Therefore, it is important to find out the physiological significance of irisin secretion and its target in matter of minutes to hours. The clinical study has limitations in correlating the irisin increase with metabolic outcomes, thus we employed primary culture system. In HSMCs, irisin downregulated ATP levels, triggering AMPK phosphorylation, with maximum phosphorylation noted at 3 hours. This led to dose-and time-dependent effects of irisin on downstream metabolic gene expression and function. Upregulation of GLUT4 and HK2, and downregulation of PDK4 and PEPCK, all point to facilitation of glucose use as an energy source. Expression of PPAR␣, suggested to act downstream of FNDC5 to partly induce UCP1 in adipocytes, was also upregulated. Decreased glycogen phosphorylase and increased glycogen synthase suggests a glycogen 'sparing' effect of irisin, possibly as a compensation for glycogen depletion postexercise. Muscle gene expression before and after endurance exercise training also showed that exercise-induced FNDC5 is related to muscle metabolic gene regulation. We confirmed that irisin-mediated gene regulation is dependent on AMPK, by the use of an AMPK inhibitor. Therefore, irisin stimulation leads to many of the classical exercise-induced changes in muscle metabolism. A recent study has reported in mouse muscle cells that irisin induces mitochondrial biogenesis and uncoupling (33) , further supporting that irisin may regulate muscle metabolism.
There are reports suggesting white adipose tissue as a source of irisin secretion (16, 34) , but the exercise-induced burst in irisin is likely accounted for skeletal muscle release alone. Furthermore, although the exercise-induced change in circulating irisin is around 10%-30%, the local concentration in skeletal muscle during exercise may well exceed those measured in the circulation. If confirmed, this will increase the relevance of our findings with regard to the effect of irisin on muscle. Significant upregulation of circulating irisin in less than 30 minutes implies that irisin release would have resulted from translational or posttranslational regulation but we also report here that FNDC5 transcription can be induced by exercise, which may prolong the effect of irisin in muscle. In other words, irisin may function as an exercise signal to facilitate muscle metabolism, irrespective of effects on adipocyte browning (13) . Also, the rapid regression of the exercise-induced irisin implies that there may also be a mechanism for irisin uptake or clearance from circulation, which has not been assessed herein.
Some studies have questioned whether irisin is an exercise-induced factor, and a large portion of this contro-versy is accounted for the use of different assay kits. We and others have validated the kit that we have used in this study, and this kit has been successful in detecting changes in irisin levels in the circulation (11, 26 -28) . Another reason for the inconsistency could be the differences in study design and lack of prior knowledge on the timeframe over which irisin is increased. In this respect, some studies have failed to detect a rise in irisin levels due to delayed sampling time (16, 18) .
Several aspects of irisin physiology remain to be elucidated. Although we have found that age and fitness level do not affect irisin levels in response to exercise, it needs to be shown whether subjects with metabolic complications such as diabetes have impaired irisin response. Moreover, the role of irisin in metabolic regulation indicates the existence of an irisin receptor, yet to be identified, which triggers downstream AMPK activation.
In conclusion, baseline irisin levels are associated with age and fitness level but exercise-induced irisin secretion is independent. The possibility of direct regulation of muscle metabolism by irisin opens a new avenue of investigation on local effects of irisin in metabolic organs and also provides the potential for future therapeutics in subjects with obesity or diabetes. Whether irisin mimics the exerciseinduced response in humans and/or may prove to have clinical applications for obese/diabetic patients need to be studied further in future observational and interventional studies. received from Bodosakis Foundation (Greece) for instrument purchase.
